CompletedPhase 3

A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301)

276 participantsStarted 2005-07

Plain-language summary

This study will attempt to find out if the addition of an intravenous form of a drug that is already used for treating asthma in children will help resolve asthma attacks faster than using the current standard care alone.

Who can participate

Age range6 Years – 14 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children 6-14 years of age seeking treatment in emergency departments with acute asthma attacks Exclusion Criteria: * Other respiratory conditions (including congenital lung abnormalities) or other acute illnesses that would complicate current treatment and response for asthma

What they're measuring

Improvement in FEV1 (Forced Expiratory Volume in 1 Second) Over the First 60 Minutes After Administration

Timeframe: Baseline and (time weighted average over) 60 Minutes

Trial details

NCT IDNCT00117338

SponsorOrganon and Co

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2008-03

Results submitted2009-03-16

View on ClinicalTrials.gov More Asthma trials